Matches in Wikidata for { <http://www.wikidata.org/entity/Q65386304> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q65386304 description "clinical trial" @default.
- Q65386304 description "ensayu clínicu" @default.
- Q65386304 description "klinisch onderzoek" @default.
- Q65386304 description "клінічне випробування" @default.
- Q65386304 name "Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma" @default.
- Q65386304 name "Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma" @default.
- Q65386304 type Item @default.
- Q65386304 label "Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma" @default.
- Q65386304 label "Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma" @default.
- Q65386304 prefLabel "Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma" @default.
- Q65386304 prefLabel "Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma" @default.
- Q65386304 P1050 Q65386304-F621ED22-16E7-404F-8E9C-BF4DDDE56DCB @default.
- Q65386304 P1132 Q65386304-FECCE879-6737-4C14-BC07-D69EA9161810 @default.
- Q65386304 P1476 Q65386304-A5B282DF-1989-4D4D-B843-F93A1FFCACF5 @default.
- Q65386304 P17 Q65386304-5494F641-D6BE-46D3-B663-15AF91BE098F @default.
- Q65386304 P17 Q65386304-69EA9445-E567-4E06-91C2-4C267F8317B0 @default.
- Q65386304 P2899 Q65386304-BC6C3B52-D731-4510-9611-3583C2F0F40D @default.
- Q65386304 P3098 Q65386304-FC4ECF94-F94B-408F-92A3-9A1BA490ECC5 @default.
- Q65386304 P31 Q65386304-940AAE06-738F-4EF1-BC19-7E0F653DA663 @default.
- Q65386304 P4844 Q65386304-9FDF8336-92B9-4B1D-BF2E-A3ADD7F2035A @default.
- Q65386304 P580 Q65386304-E06DA2D0-39FE-4653-B658-99EC47EC4E38 @default.
- Q65386304 P582 Q65386304-03E62B7E-C9CD-4C8C-BF56-4024311097C1 @default.
- Q65386304 P6099 Q65386304-B8DD9CE5-AAC8-479C-B2E8-C2DDB94D6FB5 @default.
- Q65386304 P8363 Q65386304-21F793BC-6B63-453D-92A1-D9C59CD9AC76 @default.
- Q65386304 P1050 Q35869 @default.
- Q65386304 P1132 "+475" @default.
- Q65386304 P1476 "A Randomized, Double-blind, Placebo-controlled, Parallel, Stratified, Multi-center, 12-Week Study Comparing the Safety & Efficacy of Fluticasone and Formoterol Combination (FlutiForm(tm)100/10 µg Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI)With the Administration of Placebo or Fluticasone (100 µg Twice Daily) and Formoterol (10 µg Twice Daily) Alone in Adolescent and Adult Patients With Mild to Moderate Asthma" @default.
- Q65386304 P17 Q16 @default.
- Q65386304 P17 Q30 @default.
- Q65386304 P2899 "+12" @default.
- Q65386304 P3098 "NCT00393991" @default.
- Q65386304 P31 Q30612 @default.
- Q65386304 P4844 Q27132391 @default.
- Q65386304 P580 "2006-07-01T00:00:00Z" @default.
- Q65386304 P582 "2008-04-01T00:00:00Z" @default.
- Q65386304 P6099 Q42824827 @default.
- Q65386304 P8363 Q78089383 @default.